Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The PA criteria require BMI 30 or higher (or 27 with a comorbidity such as type 2 diabetes, hypertension, dyslipidemia, OSA, or CVD), documentation of a 6-month structured weight management program, prescriber attestation that lifestyle change alone has failed, and age 18 or older
(MOUNJARO OR ZEPBOUND) is contraindicated in patients with a personal or family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) [see Contraindications (4)]
This area also provides consistent absorption rates
Most of the weight that people lose is fat mass
Treatment should be discontinued if patients have not lost at least 5% of their initial body weight after 12 weeks at the maintenance dose
US$ 22.93
US$ 25.22
US$ 21.78
US$ 23.18
